@FierceMedDev: AngioDynamics has agreed to purchase Vortex Medical for $55M. News | Follow @FierceMedDev
@MarkHFierce: Stem cells derived from skin to be tested in humans as eye disease treatment--via Bloomberg. Article | Follow @MarkHFierce
@DamianFierce: Boston Scientific will pay up to $265M for Rhythmia Medical. News | Follow @DamianFierce
> Foundation Medicine is teaming up with Eisai to handle genomic profiling and diagnostic discovery in a worldwide clinical trial of a cancer treatment. News
> SkelRegen, a startup helmed by a former Medtronic ($MDT) president and the director of Emory University Orthopaedics and Spine Center, is developing molecular compounds to regenerate bone tissue. Article
> The growing Chinese medical device market may seem alluring, but there are many pitfalls that face devicemakers looking to expand into the country, according to a report from Millennium Research Group. More
> The FDA has posted a warning letter citing Hospira ($HSP) for infusion pump manufacturing violations at its Costa Rica facility. Letter
> Navidea Biopharmaceuticals ($NAVB) is touting more positive clinical results for Lymphoseek, its diagnostic aid that has face delays on the path to FDA approval. Item
> Hygieia snagged a CE mark for its d-Nav Diabetes Insulin Guidance System, designed to update insulin dosage as needed. More
> Masimo ($MASI) got 510(k) clearance for its uSpO2 universal pulse oximetry cable, designed for use with GE Healthcare's ($GE) ApexPro Telemetry Systems. Release
> Boston Scientific ($BSX) has launched the Victory guidewire, designed to facilitate the placement of catheters and other devices in the peripheral arteries. Story
Biotech News
@FierceBiotech: Fight against 'unwarranted' drug patents goes online. FierceBiotechIT article | Follow @FierceBiotech
@JohnCFierce: Interesting. Twitter conclusion: Solanezumab a complete bust. But on BMBG, Reuters etc., it's an intriguing "win" for patients. Disconnect. | Follow @JohnCFierce
@RyanMFierce: Magic Johnson is using his celebrity to bring attention to OraSure's at-home HIV test. A good use of his celebrity, I think. | Follow @RyanMFierce
> Merck to shutter longtime NJ HQ in corporate reshuffle. News
> Billionaire Kirk orchestrates $45M cell therapy tie-up in biotech deal spree. Story
> Merck taps startup from Down Under for vaccine patch. Article
> Eli Lilly surges on conflicting data for Alzheimer's drug solanezumab. Report
Pharma News
@FiercePharma: Scotland rejects Avastin for ovarian cancer. Roche says the Scots need a cancer-drugs fund like England's. Report | Follow @FiercePharma
> Roche: Scotland needs funding for rejected cancer meds. Article
> Merck plots HQ move to former Schering site. More
> J&J eyes new Doxil process to reverse shortage. Story
Pharma Manufacturing News
> Compounder tied to meningitis deaths sold large quantities. News
> Sanofi Pasteur reports more issues with vaccine quality. Story
> Mold found in Hospira dextrose solution. Report
Biotech Research News
> Japanese scientists weld stem cells to create eggs and then baby mice. More
> RXi gains SBIR grant to pursue RNAi eye cancer drug. News
> Athersys stem cell therapy displays power as MS treatment. Article
> Inovio preclinical results prove skin delivery potency for DNA vaccines. Story